Literature DB >> 1203859

End results of radiation therapy, alone and combination with 5-fluorouracil in colorectal cancers.

V Vongtama, H O Douglass, R H Moore, E D Holyoke, J H Webster.   

Abstract

The authors retrospectively analyzed the results of irradiation in 148 cases of primary inoperable and recurrent adenocarcinoma of the colon and rectum treated at the Department of Radiation Therapy, Roswell Park Memorial Institute between 1962 and 1970. This group includes 95 recurrences and 53 inoperable primaries. Uninterrupted radiotherapy was used in 118 cases and split-course technique in 30 cases. Eleven patients received combined radiotherapy and surgery. Seventy-eight patients received a combination of 5-fluorouracil (5-FU) and irradiation. The response rate and survival of individual groups is discussed in detail. This study indicated that perineal recurrences should receive whole pelvic irradiation in addition to perineum field. Split-course technique appeared to yield a better survival than the uninterrupted course. The best 5-year survival rate (64%) is found in the group treated with a combination of radiation and surgery. For locally advanced, inoperable cancers, split-course technique, combined 5-FU and irradiation gave the best results, achieving longer palliation with improved quality of life and sometimes yielding cure (5-year survival).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1203859     DOI: 10.1002/cncr.2820360915

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  A phthalimidoalkanamide derived novel DNMT inhibitor enhanced radiosensitivity of A549 cells by inhibition of homologous recombination of DNA damage.

Authors:  Hyun-Cheol Kang; Eui Kyu Chie; Hak Jae Kim; Jin Ho Kim; Il Han Kim; Kwangsoo Kim; Beom Su Shin; EunSook Ma
Journal:  Invest New Drugs       Date:  2019-02-22       Impact factor: 3.850

2.  Pharmacokinetics of 5-fluorouracil: inter-relationship with biochemical kinetics in monitoring therapy.

Authors:  W Sadee; C G Wong
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

3.  RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.

Authors:  Arabella Young; Rachael Berry; Adele F Holloway; Nicholas B Blackburn; Joanne L Dickinson; Marketa Skala; Jessica L Phillips; Kate H Brettingham-Moore
Journal:  BMC Cancer       Date:  2014-11-04       Impact factor: 4.430

4.  Solid tumour models for the assessment of different treatment modalities: IV. the combined effects of radiation and 5-fluorouracil.

Authors:  W B Looney; J G Schaffner; J S Trefil; C J Kovacs; H A Hopkins
Journal:  Br J Cancer       Date:  1976-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.